LPL Financial’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

LPL Financial’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3	Closed	-$4K	–	3373
2019 Q1	$4K	Hold	3	–	–	﹤0.01%	3180
2018 Q4	$4K	Hold	3	–	–	﹤0.01%	3065
2018 Q3	$8K	Hold	3	–	–	﹤0.01%	3219
2018 Q2	$9K	Hold	3	–	–	﹤0.01%	3196
2018 Q1	$9K	Hold	3	–	–	﹤0.01%	3165
2017 Q4	$4K	Hold	3	–	–	﹤0.01%	3018
2017 Q3	$11K	Hold	3	–	–	﹤0.01%	2850
2017 Q2	$19K	Hold	3	–	–	﹤0.01%	2775
2017 Q1	$20K	Hold	3	–	–	﹤0.01%	2680
2016 Q4	$15K	Hold	3	–	–	﹤0.01%	2666
2016 Q3	$18K	Hold	3	–	–	﹤0.01%	2610
2016 Q2	$25K	Sell	3 -1	-25%	-$11.2K	﹤0.01%	2584
2016 Q1	$60K	Buy	4 +3	+300%	+$67.9K	﹤0.01%	2987
2015 Q4	$28K	Buy	+1	New	+$18.9K	﹤0.01%	3092

Other funds holding TMBR

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NFG

Nadler Financial Group Deerfield, Illinois $1.04B AUM 19.04% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

LPL Financial's TMBR Position: Q2 2019 in Review

LPL Financial sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q2 2019, closing a stake of 3 shares — an estimated $4K sold.

LPL Financial first reported a position in TMBR in Q4 2015 and held it in 14 quarters. The position peaked at $60K in Q1 2016. 14 funds tracked by Wall St. Rank hold TMBR as of Q2 2019.

LPL Financial reported no remaining Timber Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
LPL Financial sold 3 Timber Pharmaceuticals, Inc. shares in Q2 2019, an estimated $4K.
LPL Financial first reported a position in Timber Pharmaceuticals, Inc. in Q4 2015 and held it in 14 quarters.
LPL Financial's Timber Pharmaceuticals, Inc. position peaked at $60K in Q1 2016.
14 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q2 2019.

Based on LPL Financial's 13F filing for Q2 2019, filed 9 Aug 2019.